DETAILED ACTION
Notice of Pre-AIA or AIA Status
The present application is being examined under the pre-AIA first to invent provisions.
Priority
This application is a continuation (CON) application of U.S. Application Serial Number 18/534,083, filed 12/08/2023, which is a divisional (DIV) application of U.S. Application Serial Number 13/844,544, filed 3/15/2013, which is a continuation-in-part (CIP) of PCT/US2012/060010, filed 10/12/2012. This application claims benefit to U.S. Provisional Applications Serial Number 61/581,679, filed 12/30/2011 and Serial Number 61/627,633, filed 10/13/2011. Claims 41-60 are pending and have been examined on the merits.
Information Disclosure Statement
The information disclosure statement submitted on 5/14/2025 has been considered by the examiner.
Claim Rejections - 35 USC § 112
The following is a quotation of 35 U.S.C. 112(b):
(b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention.
The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph:
The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention.
Claims 56 and 60 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention.
The term “about” in claims 56 and 60 is a relative term which renders the claims indefinite. The term “about” is not defined by the claim, the specification does not provide a standard for ascertaining the requisite degree, and one of ordinary skill in the art would not be reasonably apprised of the scope of the invention. Thus, claims 56 and 60 are rejected under 35 U.S.C. 112(b) as being indefinite.
Double Patenting
The nonstatutory double patenting rejection is based on a judicially created doctrine grounded in public policy (a policy reflected in the statute) so as to prevent the unjustified or improper timewise extension of the “right to exclude” granted by a patent and to prevent possible harassment by multiple assignees. A nonstatutory double patenting rejection is appropriate where the conflicting claims are not identical, but at least one examined application claim is not patentably distinct from the reference claim(s) because the examined application claim is either anticipated by, or would have been obvious over, the reference claim(s). See, e.g., In re Berg, 140 F.3d 1428, 46 USPQ2d 1226 (Fed. Cir. 1998); In re Goodman, 11 F.3d 1046, 29 USPQ2d 2010 (Fed. Cir. 1993); In re Longi, 759 F.2d 887, 225 USPQ 645 (Fed. Cir. 1985); In re Van Ornum, 686 F.2d 937, 214 USPQ 761 (CCPA 1982); In re Vogel, 422 F.2d 438, 164 USPQ 619 (CCPA 1970); In re Thorington, 418 F.2d 528, 163 USPQ 644 (CCPA 1969).
A timely filed terminal disclaimer in compliance with 37 CFR 1.321(c) or 1.321(d) may be used to overcome an actual or provisional rejection based on nonstatutory double patenting provided the reference application or patent either is shown to be commonly owned with the examined application, or claims an invention made as a result of activities undertaken within the scope of a joint research agreement. See MPEP § 717.02 for applications subject to examination under the first inventor to file provisions of the AIA as explained in MPEP § 2159. See MPEP § 2146 et seq. for applications not subject to examination under the first inventor to file provisions of the AIA . A terminal disclaimer must be signed in compliance with 37 CFR 1.321(b).
The filing of a terminal disclaimer by itself is not a complete reply to a nonstatutory double patenting (NSDP) rejection. A complete reply requires that the terminal disclaimer be accompanied by a reply requesting reconsideration of the prior Office action. Even where the NSDP rejection is provisional the reply must be complete. See MPEP § 804, subsection I.B.1. For a reply to a non-final Office action, see 37 CFR 1.111(a). For a reply to final Office action, see 37 CFR 1.113(c). A request for reconsideration while not provided for in 37 CFR 1.113(c) may be filed after final for consideration. See MPEP §§ 706.07(e) and 714.13.
The USPTO Internet website contains terminal disclaimer forms which may be used. Please visit www.uspto.gov/patent/patents-forms. The actual filing date of the application in which the form is filed determines what form (e.g., PTO/SB/25, PTO/SB/26, PTO/AIA /25, or PTO/AIA /26) should be used. A web-based eTerminal Disclaimer may be filled out completely online using web-screens. An eTerminal Disclaimer that meets all requirements is auto-processed and approved immediately upon submission. For more information about eTerminal Disclaimers, refer to www.uspto.gov/patents/apply/applying-online/eterminal-disclaimer.
Claims 41-48, 51-54 and 56-60 are rejected on the ground of nonstatutory double patenting as being unpatentable over claims 1-5, 7 and 11-14 of U.S. Patent No. 11999940 (herein “’940”).
Although the claims at issue are not identical, they are not patentably distinct from each other because claim 1 of ‘940 recites a method for processing organic material in a four-phase bioreactor system into a final product containing microbial consortiums and by-products with a chemical oxygen demand (COD) of less than 150 mg/L, wherein movement of said organic material from one phase to the next is hydraulically balanced, and wherein the temperature of said process is maintained between 29° C. and 39° C., the method comprising: (a) adding organic feedstock comprising the organic material to said four-phase bioreactor system at a feed rate in a range of 0.001 to about 0.1 pound of organic feedstock per cubic foot of a total working capacity of said four-phase bioreactor system per day; (b) passing a working fluid containing said organic material through said four-phase bioreactor system while the working fluid is subjected to four phases comprising: (i) a first phase in which said organic material is hydrolyzed to obtain a material of step (i), and in which microbes having methanogen and sulfur-reducing metabolisms, as determined by 16S rRNA gene sequencing, have dominance; (ii) a second phase in which said material of step (i) is subject to acidogenesis and acetogenesis to obtain a material of step (ii) which comprises methanogenic precursors hydrogen, carbon dioxide, and acetate; (iii) a third phase conducted in a plurality of packed bed reactors to obtain a material of step (iii) wherein each packed bed reactor comprises a fixed media providing a platform for anchoring biofilm and wherein said methanogenic precursors of the material of step (ii) are subjected to methanogenesis and converted to methane, the methane is subjected to methanotrophy, methanotrophs are more abundant than methanogens in the working fluid of said third phase, and at least a portion of the material of step (ii) is subjected to nitrification; and (iv) a fourth phase, in which said material of step (iii) is stabilized to produce said final product; claim 11 of ‘940 recites the method according to claim 1, wherein said hydraulically balanced movement of said organic material from one phase to the next enables said organic material to continuously move in a fixed direction and rate of flow; claim 12 of ‘940 recites the method according to claim 1, wherein microbes having nitrification and denitrification metabolisms, as determined by 16S rRNA gene sequencing, have dominance in the second phase; claim 13 of ‘940 recites the method according to claim 1, wherein microbes having nitrification and methanotroph metabolisms, as determined by 16S rRNA gene sequencing, have dominance in the third phase space; and claim 14 of ‘940 recites the method according to claim 1, wherein microbes having nitrification and denitrification metabolisms, as determined by 16S rRNA gene sequencing, have dominance in the fourth phase space; hence, a person of ordinary skill in the art at the time of filing would have found it obvious to practice a method of producing a product from a first organic material using a multiphase bioreactor, the method comprising: subjecting a working fluid comprising the first organic material to: (i) a first phase space of the multiphase bioreactor in which the first organic material is hydrolyzed to generate a second organic material, wherein the first phase space comprises an abundance of microbes comprising sulfur-reducing metabolism that is greater than an abundance of microbes comprising denitrification metabolism, nitrification metabolism, methanotroph metabolism, or any combination thereof; (ii) a second phase space of the multiphase bioreactor in which the second organic material is used to generate a third organic material comprising methanogenic precursors; (iii) a third phase space of the multiphase bioreactor in which the third organic material is used to generate a fourth organic material, wherein the third phase space comprises an abundance of microbes having denitrification metabolism that is greater than an abundance of microbes having methanogen metabolism; and (iv) a fourth phase space of the multiphase bioreactor in which the fourth organic material is stabilized to produce the product, wherein the abundance of microbes comprising sulfur-reducing metabolism, the abundance of microbes comprising denitrification metabolism, nitrification metabolism, methanotroph metabolism, or any combination thereof, the abundance of microbes having denitrification metabolism, and the abundance of microbes having methanogen metabolism is determined by 16S rRNA gene amplicon-based sequencing, wherein the first phase space further comprises an abundance of microbes having methanogen metabolism and sulfur-reducing metabolism that is greater than the abundance of microbes having denitrification metabolism, nitrification metabolism, methanotroph metabolism, or any combination thereof as determined by 16S rRNA gene amplicon-based sequencing, wherein the first phase space comprises an abundance of microbes having sulfur-reducing metabolism that is greater than an abundance of microbes having denitrification metabolism as determined by 16S rRNA gene amplicon-based sequencing, wherein the first phase space comprises an abundance of microbes having sulfur-reducing metabolism that is greater than an abundance of microbes having nitrification metabolism as determined by 16S rRNA gene amplicon-based sequencing, wherein the first phase space comprises an abundance of microbes having sulfur-reducing metabolism that is greater than an abundance of microbes having methanotroph metabolism as determined by 16S rRNA gene amplicon-based sequencing, wherein the first phase space comprises the abundance of microbes having sulfur-reducing metabolism that is greater than an abundance of microbes having denitrification metabolism, nitrification metabolism, and methanotroph metabolism as determined by 16S rRNA gene amplicon-based sequencing, wherein the third phase space further comprises an abundance of microbes having methanotroph metabolism and microbes having denitrification metabolism that is greater than the abundance of microbes having methanogen metabolism as determined by 16S rRNA gene amplicon-based sequencing, wherein the first phase space, second phase space, third phase space, and four phase space comprise packed bed reactors comprising a fixed media providing a platform for anchoring biofilm, wherein the subjecting comprises continuously moving the working fluid from the first phase space to the second phase space, from the second phase space to the third phase space, and from the third phase space to the fourth phase space in a fixed direction and rate of flow, wherein a microbial community of the biofilm comprises a microbe having anammox metabolism, iron-oxidation metabolism, aromatic degrading metabolism, methanogen metabolism, sulfur-oxidation metabolism, or any combination thereof, wherein the organic feedstock is provided to the first phase space at a feed rate in a range of 0.001 to about 0.1 pound of organic feedstock per cubic foot of a total working capacity of a multiphase bioreactor per day; therefore, instant claims 41-48, 51-52, 54 and 60 are prima facie obvious over claims 1 and 11-14 of ‘940.
Claim 3 of ‘940 recites the method according to claim 1, wherein said method further comprises: (a) obtaining a set of phase profiles for each phase; (b) monitoring a set of physical data from each phase; (c) comparing the set of phase profiles from each phase to the set of physical data from each phase; (d) deriving a control response to each phase based on the comparison of (c); and (e) applying the control response to each phase; hence, a person of ordinary skill in the art at the time of filing would have found it obvious for the method made obvious by claims 1 and 11-14 of ‘940 to further comprise (i) receiving a set of phase profiles for the first phase space, the second phase space, the third phase space, the fourth phase space, or any combination thereof; (ii) monitoring a set of physical data from the first phase space, the second phase space, the third phase space, the fourth phase space, or any combination thereof; and (iii) comparing the set of phase profiles to the set of physical data; therefore, instant claim 57 is prima facie obvious.
Claim 2 of ‘940 recites the method according to claim 1, wherein said method further comprises pasteurization and/or concentration of the final product; hence, a person of ordinary skill in the art at the time of filing would have found it obvious for the method made obvious by claims 1 and 11-14 of ‘940 to further comprise pasteurizing the product or concentrating the product; therefore, instant claim 58 is prima facie obvious.
Claim 5 of ‘940 recites the method according to claim 1, wherein said organic material is processed to obtain biostimulants, soil amendments or soil additives, wherein the biostimulants, soil amendments, or soil additives are capable of promoting growth and/or increasing biomass of a plant; hence, a person of ordinary skill in the art at the time of filing would have found it obvious for the method made obvious by claims 1 and 11-14 of ‘940 to further comprise processing the fourth organic material to obtain biostimulants, soil amendments, soil additives, or any combination thereof, wherein the biostimulants, soil amendments, soil additives, or any combination thereof are configured to promote growth of a plant or increase a biomass of a plant; therefore, instant claim 59 is prima facie obvious.
Regarding instant claim 53, claim 11 of ‘940 recites the method according to claim 1, wherein said hydraulically balanced movement of said organic material from one phase to the next enables said organic material to continuously move in a fixed direction and rate of flow; hence, a person of ordinary skill in the art at the time of filing would have found it obvious that the process comprises a recycle rate within each phase as well as a rate of passing on to the next phase, i.e., hydraulically balanced, but does not suggest what the recycle rate, i.e., in gallons per minute, should be; however, the recycle rate would influence the amount of hydrolysis, acetogenesis, methanogenesis, denitrification and stabilization of the organic matter that occurs in each phase of the process; hence, a person of ordinary skill in the art at the time of filing would have found it obvious that the recycle rate is a result effective variable which has an obvious effect on parameters such as the degree of hydrolysis, acetogenesis, methanogenesis, denitrification and stabilization that occurs in the process. Therefore, a person of ordinary skill in the art would find it obvious to vary this parameter to produce the plant growth biostimulant that met the perceived need and would reach a working fluid rate ratio of 30 gallons per minute of a recycle rate to 1 gallon per minute of a hydraulic feed rate; therefore, claim 53 is prima facie obvious. See also MPEP 2144.05 II.A. “Generally, differences in concentration or temperature will not support the patentability of subject matter encompassed by the prior art unless there is evidence indicating such concentration or temperature is critical. “[W]here the general conditions of a claim are disclosed in the prior art, it is not inventive to discover the optimum or workable ranges by routine experimentation.” In re Aller, 220 F.2d 454, 456, 105 USPQ 233, 235 (CCPA 1955) (Claimed process which was performed at a temperature between 40°C and 80°C and an acid concentration between 25% and 70% was held to be prima facie obvious over a reference process which differed from the claims only in that the reference process was performed at a temperature of 100°C and an acid concentration of 10%)".
Regarding instant claim 56, claim 4 of ‘940 recites the method according to claim 1, wherein said organic material provided to the first phase comprises water and a dry active yeast. The claims of ‘940 do not disclose the concentration of dry active yeast in the organic material provided to the process at a feed rate of 0.001 to 0.1 pound of organic feedstock per cubic foot of total working capacity of the four-phase bioreactor; however, the concentration of the dry active yeast is a result effective variable and a person of ordinary skill in the art would expect the concentration of the yeast in the organic material to have an obvious effect on the composition of the plant growth biostimulant. Therefore, a person of ordinary skill in the art would find it obvious to vary this parameter to get the plant growth biostimulant that met the perceived need. Hence, a person of ordinary skill in the art at the time of filing would have found it obvious to optimize the concentration of the dry active yeast to produce the desired plant growth biostimulant and would arrive at the claimed concentration of between about 0.2 pounds dry active yeast per 5000 gallons of the working fluid to about 2 pounds dry active yeast per 5000 gallons of the working fluid; therefore, claim 56 is prima facie obvious.
See also MPEP 2144.05 II.A. “Generally, differences in concentration or temperature will not support the patentability of subject matter encompassed by the prior art unless there is evidence indicating such concentration or temperature is critical. “[W]here the general conditions of a claim are disclosed in the prior art, it is not inventive to discover the optimum or workable ranges by routine experimentation.” In re Aller, 220 F.2d 454, 456, 105 USPQ 233, 235 (CCPA 1955) (Claimed process which was performed at a temperature between 40°C and 80°C and an acid concentration between 25% and 70% was held to be prima facie obvious over a reference process which differed from the claims only in that the reference process was performed at a temperature of 100°C and an acid concentration of 10%)".
Claims 41-60 are provisionally rejected on the ground of nonstatutory double patenting as being unpatentable over claims 1-5, 8 and 10-14 of U.S. Patent No. 11999940 (herein “’940”) in view of claims 2-3, 6-10 and 15-18 of co-pending application 18/534083 (herein “’083”).
The discussion of claims 1-3, 5 and 11-14 of ‘940 regarding instant claims 41-48, 51-54 and 56-60 set forth in the rejection above is incorporated herein.
Claims 1, 5, 8 and 10 of ‘940 make obvious a process for producing a plant growth biostimulant from organic material wherein the organic material comprises denitrifying bacteria, e.g., from cow manure, and dry active yeast wherein the plant growth biostimulant has a chemical oxygen demand (COD) of 90 – 120 mg/L, but the claims of ‘940 do not specifically recite that the plant growth biostimulant comprises a microbial consortium comprising one or more microorganisms of a genera selected from the group consisting of: Syntrophus, Desulfovibrio, Symbiobacterium, Thauera, Nitrosomonas, Bellilinea, Sulfuritalea, and Owenweeksia; however, a person of ordinary skill in the art at the time of filing would have found it obvious for the plant growth biostimulant to comprises a microbial consortium comprising one or more microorganisms of a genera selected from the group consisting of: Syntrophus, Desulfovibrio, Symbiobacterium, Thauera, Nitrosomonas, Bellilinea, Sulfuritalea, and Owenweeksia in view of claims 2-3, 6-10 and 15-18 of ‘083.
Claim 2 of ‘083 recites a method for promoting plant growth comprising contacting a plant or plant growth medium with a composition comprising microbial digestion products of an organic material, wherein the microbial digestion products comprise one or more methanotroph digestion products, and wherein the composition has a chemical oxygen demand (COD) level of less than 150 mg/L; claim 3 of ‘083 recites the method of claim 2, wherein the contacting increases a biomass of the plant; claim 6 of ‘083 recites the method of claim 2, wherein the composition has a COD level from 90 mg/L to 120 mg/L; claim 7 of ‘083 recites the method of claim 2, wherein the composition further comprises a microbial consortium; claim 8 of ‘083 recites the method of claim 7, wherein the microbial consortium comprises at least one microorganism from a genera selected from the group consisting of: Syntrophus, Desulfovibrio, Symbiobacteria, Georgfuschia, Thauera, Nitrosomonas, Bellilinea, Sulfuritalea, and Owenweeksia; claim 9 of ‘083 recites the method of claim 8, wherein the microbial consortium comprises at least one microorganism from each of the genera selected from the group consisting of: Syntrophus, Desulfovibrio, Symbiobacteria, Georgfuschia, Thauera, Nitrosomonas, Bellilinea, Sulfuritalea, and Owenweeksia; claim 10 of ‘083 recites the method of claim 7, wherein the microbial consortium comprises at least 8 different microbial species; claim 15 of ‘083 recites the method of claim 2, wherein the organic material comprises manure; claim 16 of ‘083 recites the method of claim 15, wherein the manure is cow manure; claim 17 of ‘083 recites the method of claim 16, wherein the organic material further comprises a dry active yeast; and claim 18 of ‘083 recites the method of claim 2, wherein the organic material comprises a denitrifying bacterium, a methanogen, a sulfur-reducing bacterium, a dechlorinating bacterium, an aromatic degrading bacterium, a nitrifying bacterium, a sulfur-oxidizing bacterium, an iron-oxidizing bacterium, an anaerobic ammonium oxidizing bacterium, or any combination thereof. Hence, a person of ordinary skill in the art at the time of filing would have found it obvious that the plant growth biostimulant product of the process made obvious by the claims of ‘940 comprises a microbial consortium comprising Syntrophus, Desulfovibrio, Symbiobacteria, Georgfuschia, Thauera, Nitrosomonas, Bellilinea, Sulfuritalea, and Owenweeksia because the process made obvious by the claims of ‘940 comprises the microbial digestion of an organic material comprising denitrifying bacteria, e.g., cow manure, and dry active yeast wherein the resultant plant growth biostimulant product increases the biomass of a plant and comprises a COD of 90 – 120 mg/L and the claims of ‘083 disclose that microbial digestion of organic material comprising cow manure and dry active yeast with a COD of 90 – 120 mg/L comprise a microbial consortium comprising bacteria from each of Syntrophus, Desulfovibrio, Symbiobacteria, Georgfuschia, Thauera, Nitrosomonas, Bellilinea, Sulfuritalea, and Owenweeksia; therefore, claims 49-50 are prima facie obvious.
Regarding instant claim 55, claims 9 and 18 of ‘083 make obvious that the microbial consortium of the plant growth biostimulant product comprises microbes with anaerobic ammonium oxidation (anammox) activity because claim 9 recites that the microbial consortium comprises Owenweeksia, which is an anammox microbe (specification, Table 7) and claim 18 recites that the microbial consortium can comprise anaerobic ammonium oxidizing bacteria, i.e., anammox microbes. A person of ordinary skill in the art at the time of filing would have found it obvious that the anammox microbes can be localized in biofilms; hence, a person of ordinary skill in the art at the time of filing would have found it obvious for the microbial community of the biofilm of the first phase space, the second phase space, the third phase space, or the fourth phase space to comprise a greater abundance of microbes comprising anammox metabolism compared to an abundance of microbes comprising anammox metabolism in the working fluid in the respective first phase space, the second phase space, the third phase space, or the fourth phase space; therefore, instant claim 55 is prima facie obvious.
This is a provisional nonstatutory double patenting rejection.
Claims 41-60 are rejected on the ground of nonstatutory double patenting as being unpatentable over claims 1-7, 10-11 and 17-18 of U.S. Patent No. 11692163 (herein “’163”).
Although the claims at issue are not identical, they are not patentably distinct from each other because claim 1 of ‘163 recites a method for processing an organic feedstock into a soil amendment final product having microbial consortiums for promoting growth or increasing biomass of a plant, the method comprising: adding the organic feedstock to a first phase space of a bioreactor system to form a working fluid, wherein the feedstock is added to the bioreactor system at a feed rate of about 0.001 to 0.1 pounds of feedstock per cubic foot of a total working capacity of the bioreactor system per day and movement of the working fluid through the bioreactor system is hydraulically balanced; producing methane and reducing sulfate in the first phase space wherein microbes having methanogen and sulfur-reducing metabolisms, as determined by sequences of PCR-amplified 16S rRNA gene fragments, have dominance in the first phase space; passing the working fluid from the first phase space to a second phase space of the bioreactor system, wherein microbes having nitrification and denitrification metabolisms, as determined by sequences of PCR-amplified 16S rRNA gene fragments, have dominance in the second phase space; passing working fluid from the second phase space to a third phase space of the bioreactor system, wherein the third phase space includes packed bed reactors and each packed bed reactor includes a fixed media that provides a platform for anchoring biofilm; oxidizing methane to carbon dioxide and oxidizing ammonium to nitrate and nitrite in the third phase space, wherein microbes having nitrification and methanotroph metabolisms. as determined by sequences of PCR-amplified 16S rRNA gene fragments, have dominance in the third phase space; passing the working fluid from the third phase space to a fourth phase space of the bioreactor system, wherein microbes having nitrification and denitrification metabolisms, as determined by sequences of PCR-amplified 16S rRNA gene fragments have dominance in the fourth phase space; and passing the working fluid through an outlet from the fourth phase space to a storage tank or for further processing to produce the final product, wherein the working fluid is maintained at a temperature of 29° C to 39° C in the first phase space, the second phase space, the third phase space and the fourth phase space; and claim 17 of ‘163 recites the method of claim 1 wherein the second phase space includes packed bed reactors and each packed bed reactor includes a fixed media providing a platform for anchoring biofilm; hence, a person of ordinary skill in the art at the time of filing would have found it obvious to practice a method of producing a product from a first organic material using a multiphase bioreactor, the method comprising: subjecting a working fluid comprising the first organic material to: (i) a first phase space of the multiphase bioreactor in which the first organic material is hydrolyzed to generate a second organic material, wherein the first phase space comprises an abundance of microbes comprising sulfur-reducing metabolism that is greater than an abundance of microbes comprising denitrification metabolism, nitrification metabolism, methanotroph metabolism, or any combination thereof; (ii) a second phase space of the multiphase bioreactor in which the second organic material is used to generate a third organic material comprising methanogenic precursors; (iii) a third phase space of the multiphase bioreactor in which the third organic material is used to generate a fourth organic material, wherein the third phase space comprises an abundance of microbes having denitrification metabolism that is greater than an abundance of microbes having methanogen metabolism; and (iv) a fourth phase space of the multiphase bioreactor in which the fourth organic material is stabilized to produce the product, wherein the abundance of microbes comprising sulfur-reducing metabolism, the abundance of microbes comprising denitrification metabolism, nitrification metabolism, methanotroph metabolism, or any combination thereof, the abundance of microbes having denitrification metabolism, and the abundance of microbes having methanogen metabolism is determined by 16S rRNA gene amplicon-based sequencing, wherein the first phase space further comprises an abundance of microbes having methanogen metabolism and sulfur-reducing metabolism that is greater than the abundance of microbes having denitrification metabolism, nitrification metabolism, methanotroph metabolism, or any combination thereof as determined by 16S rRNA gene amplicon-based sequencing, wherein the first phase space comprises an abundance of microbes having sulfur-reducing metabolism that is greater than an abundance of microbes having denitrification metabolism as determined by 16S rRNA gene amplicon-based sequencing, wherein the first phase space comprises an abundance of microbes having sulfur-reducing metabolism that is greater than an abundance of microbes having nitrification metabolism as determined by 16S rRNA gene amplicon-based sequencing, wherein the first phase space comprises an abundance of microbes having sulfur-reducing metabolism that is greater than an abundance of microbes having methanotroph metabolism as determined by 16S rRNA gene amplicon-based sequencing, wherein the first phase space comprises the abundance of microbes having sulfur-reducing metabolism that is greater than an abundance of microbes having denitrification metabolism, nitrification metabolism, and methanotroph metabolism as determined by 16S rRNA gene amplicon-based sequencing, wherein the third phase space further comprises an abundance of microbes having methanotroph metabolism and microbes having denitrification metabolism that is greater than the abundance of microbes having methanogen metabolism as determined by 16S rRNA gene amplicon-based sequencing, wherein the first phase space, second phase space, third phase space, and four phase space comprise packed bed reactors comprising a fixed media providing a platform for anchoring biofilm, wherein the subjecting comprises continuously moving the working fluid from the first phase space to the second phase space, from the second phase space to the third phase space, and from the third phase space to the fourth phase space in a fixed direction and rate of flow, wherein a microbial community of the biofilm comprises a microbe having anammox metabolism, iron-oxidation metabolism, aromatic degrading metabolism, methanogen metabolism, sulfur-oxidation metabolism, or any combination thereof, wherein the organic feedstock is provided to the first phase space at a feed rate in a range of 0.001 to about 0.1 pound of organic feedstock per cubic foot of a total working capacity of a multiphase bioreactor per day; therefore, instant claims 41-48, 51-52, 54 and 59-60 are prima facie obvious over claims 1 and 17 of ‘163.
Claim 18 of ‘163 recites the method of claim 1 wherein the final product has the following characteristics: (a) has a pH of about 7.5 to 8; (b) chemical oxygen demand of less than about 150 mg/L; (c) conductivity range of about 600 µS/cm to 1400 µS/cm; (d) color clear amber between about 500 pt/co units to about 700 pt/co units in a platinum to cobalt (pt/co) scale; (e) comprises Syntrophus, Desulfovibrio, Symbiobacteria, Georgfuschia, Thauera, Nitrosomonas, Bellilinea, Sulfuritalea and Owenweeksia; (f) has a biomass greater than 107 microbes per ml; (g) contains between about 10-60 ng/ml DNA; and (h) comprises at least eight microbial species; hence, a person of ordinary skill in the art at the time of filing would have found it obvious that the product comprises a microbial consortium comprising one or more microorganisms of a genera selected from the group consisting of: Syntrophus, Desulfovibrio, Symbiobacterium, Thauera, Nitrosomonas, Bellilinea, Sulfuritalea, and Owenweeksia; therefore, instant claims 49-50 are prima facie obvious.
Regarding instant claim 53, claim 4 of ‘163 recites the method of claim 2 wherein if the COD of the second phase space, third phase space or fourth phase space is below a phase profile COD level, a hydraulic feed rate to internal recycle rate ratio is increased or a dwell time is decreased; hence, a person of ordinary skill in the art at the time of filing would have found it obvious that the process comprises a recycle rate within each phase as well as a rate of passing on to the next phase, i.e., hydraulically balanced, but does not suggest what the recycle rate, i.e., in gallons per minute, should be; however, the recycle rate would influence the amount of hydrolysis, acetogenesis, methanogenesis, denitrification and stabilization of the organic matter that occurs in each phase of the process; hence, a person of ordinary skill in the art at the time of filing would have found it obvious that the recycle rate is a result effective variable which has an obvious effect on parameters such as the degree of hydrolysis, acetogenesis, methanogenesis, denitrification and stabilization that occurs in the process. Therefore, a person of ordinary skill in the art would find it obvious to vary this parameter to produce the plant growth biostimulant that met the perceived need and would reach a working fluid rate ratio of 30 gallons per minute of a recycle rate to 1 gallon per minute of a hydraulic feed rate; therefore, claim 53 is prima facie obvious. See also MPEP 2144.05 II.A. “Generally, differences in concentration or temperature will not support the patentability of subject matter encompassed by the prior art unless there is evidence indicating such concentration or temperature is critical. “[W]here the general conditions of a claim are disclosed in the prior art, it is not inventive to discover the optimum or workable ranges by routine experimentation.” In re Aller, 220 F.2d 454, 456, 105 USPQ 233, 235 (CCPA 1955) (Claimed process which was performed at a temperature between 40°C and 80°C and an acid concentration between 25% and 70% was held to be prima facie obvious over a reference process which differed from the claims only in that the reference process was performed at a temperature of 100°C and an acid concentration of 10%)".
Regarding instant claim 55, claim 18 of ‘163 make obvious that the microbial consortium of the plant growth biostimulant product comprises microbes with anaerobic ammonium oxidation (anammox) activity because claim 18 recites that the microbial consortium comprises Owenweeksia, which is a microbe comprising anammox metabolism (specification, Table 7). A person of ordinary skill in the art at the time of filing would have found it obvious that the anammox microbes can be localized in biofilms; hence, a person of ordinary skill in the art at the time of filing would have found it obvious for the microbial community of the biofilm of the first phase space, the second phase space, the third phase space, or the fourth phase space to comprise a greater abundance of microbes comprising anammox metabolism compared to an abundance of microbes comprising anammox metabolism in the working fluid in the respective first phase space, the second phase space, the third phase space, or the fourth phase space; therefore, instant claim 55 is prima facie obvious.
Regarding instant claim 56, claim 6 of ‘163 recites the method of claim 1 further comprising adding yeast to the working fluid in the first phase space and claim 7 of ‘163 recites the method of claim 6, wherein adding yeast comprises adding dry active yeast into the working fluid in an amount of about 0.2 to about 2 pounds dry active yeast per 5000 gallons of working fluid; therefore, claim 56 is prima facie obvious.
Regarding instant claim 57, claim 2 of ‘163 recites the method of claim 1 further comprising: maintaining the working fluid in the first phase space at a pH of about 6.2 to 7.9, a chemical oxygen demand (COD) of about 400 mg/L to 2000 mg/L and a conductivity of about 500 μS/cm to 2000 μS/cm; maintaining the working fluid in the second phase space at a pH of about 6.0 to 8.0, a COD of about 100 mg/L to 400 mg/L, and a conductivity of about 1000 μS/cm to 1600 μS/cm; maintaining the working fluid of the third phase space at a pH of about 7.0 to 8.0, a chemical oxygen demand (COD) of about 100 mg/L to 400 mg/L, and a conductivity of about 700 μS/cm to 1500 μS/cm; and maintaining the working fluid in the fourth phase space at a pH of about 7.6 to 8.3, a COD of about 80 mg/L to 150 mg/L, and a conductivity of about 900 μS/cm to 1200 μS/cm; claim 3 of ‘163 recites the method of claim 2 wherein if the pH level of the second phase space, third phase space or fourth phase space is below a phase profile pH level, a hydraulic feed rate to internal recycle rate ratio is increased or a dwell time is decreased; claim 4 of ‘163 recites the method of claim 2 wherein if the COD of the second phase space, third phase space or fourth phase space is below a phase profile COD level, a hydraulic feed rate to internal recycle rate ratio is increased or a dwell time is decreased; and claim 5 of ‘163 recites the method of claim 2 wherein if the conductivity of the second phase space, third phase space or fourth phase space is below a phase profile conductivity level, a hydraulic feed rate to internal recycle rate ratio is increased or a dwell time is decreased; hence, a person of ordinary skill in the art at the time of filing would have found it obvious to practice the method made obvious by the claims of ‘163 further comprising (i) receiving a set of phase profiles for the first phase space, the second phase space, the third phase space, the fourth phase space, or any combination thereof; (ii) monitoring a set of physical data from the first phase space, the second phase space, the third phase space, the fourth phase space, or any combination thereof; and (iii) comparing the set of phase profiles to the set of physical data; therefore, instant claim 57 is prima facie obvious.
Claim 10 of ‘163 recites the method of claim 1 further comprising pasteurizing the working fluid from the outlet and claim 11 of ‘163 recites the method of claim 1 further comprising concentrating the working fluid from the outlet; hence, a person of ordinary skill in the art at the time of filing would have found it obvious to practice the method made obvious by the claims of ‘163 further comprising pasteurizing the product or concentrating the product; therefore, instant claim 59 is prima facie obvious.
Allowable Subject Matter
The process of claims 41-60 is novel and non-obvious over the prior art. The closest prior art is Pynaert et al., 2004 (cite U, attached PTO-982; herein “Pynaert”) which discloses a process for producing a product from a first organic material using a multiphase bioreactor, the method comprising a multiphase bioreactor comprising methanogenic, nitrifying and denitrifying activities wherein the abundance of microbes comprising denitrification metabolism and nitrification metabolism is determined by 16S rRNA gene amplicon-based sequencing (Abst.; pp. 1228-1229, “Introduction”). Pynaert discloses a process for producing a product from a first organic material using a multiphase bioreactor wherein one or more of the phases comprise methanogenic, nitrifying and denitrifying activities wherein the abundance of microbes comprising denitrification metabolism and nitrification metabolism is determined by 16S rRNA gene amplicon-based sequencing, but does not disclose that the first phase of the multiphase bioreactor comprises an abundance of microbes comprising sulfur-reducing metabolism that is greater than an abundance of microbes comprising denitrification metabolism, nitrification metabolism, methanotroph metabolism, or any combination thereof. No prior art alone or in combination with Pynaert makes obvious the claimed invention; hence, claims 41-60 are allowable after fixing the 112(b) issues set forth above and the filing of terminal disclaimers over US Patents 11999940 and 11692163 and co-pending application 18/534083 (NOTE: a Notice of Allowance was mailed for application 18/534083 and the issue fee has been paid but the patent number has not been assigned as of the posting date of this Office action).
Conclusion
No claims are allowed.
Any inquiry concerning this communication or earlier communications from the examiner should be directed to Trent R Clarke whose telephone number is (571)272-2904. The examiner can normally be reached M-F 10-7 MST.
Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice.
If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Melenie Gordon can be reached at 571-272-8037. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300.
Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000.
/TRENT R CLARKE/ Examiner, Art Unit 1651
/DAVID W BERKE-SCHLESSEL/ Primary Examiner, Art Unit 1651